Sequoia Financial Advisors LLC Sells 12,841 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sequoia Financial Advisors LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 58.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,102 shares of the company’s stock after selling 12,841 shares during the period. Sequoia Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $827,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Fortitude Family Office LLC acquired a new position in shares of GE HealthCare Technologies in the fourth quarter worth approximately $29,000. Turtle Creek Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $30,000. Sachetta LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $31,000. Rise Advisors LLC increased its position in shares of GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after buying an additional 239 shares during the period. Finally, Riverview Trust Co bought a new position in GE HealthCare Technologies during the first quarter worth $31,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at GE HealthCare Technologies

In related news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CTO Taha Kass-Hout sold 3,300 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Frank R. Jimenez purchased 1,315 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Insiders sold a total of 90,482 shares of company stock worth $7,369,137 in the last quarter. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Trading Down 0.2 %

GEHC opened at $77.06 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The firm has a market capitalization of $35.17 billion, a PE ratio of 22.53, a P/E/G ratio of 2.77 and a beta of 1.20. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The company’s 50-day moving average is $78.94 and its 200 day moving average is $81.86.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting the consensus estimate of $0.90. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.85 earnings per share. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

Analysts Set New Price Targets

A number of analysts have commented on GEHC shares. Mizuho cut their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Evercore ISI raised their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Bank of America dropped their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Finally, Argus boosted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.09.

View Our Latest Report on GEHC

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.